1 and seven transplant recipients with chronic
hepatitis E.
2 or the development of new strategies against
hepatitis E.
3 injury in an era of increasing awareness of
hepatitis E.
4 en made in the prevention of hepatitis A and
hepatitis E.
5 rovide a basis for developing treatments for
hepatitis E.
6 Moldova, a country without reported cases of
hepatitis E.
7 eveloped that offer the potential to prevent
hepatitis E.
8 id monotherapy for acute liver injury due to
hepatitis E.
9 ed cases of possible transfusion-transmitted
hepatitis E.
10 oping effective therapeutics against chronic
hepatitis E.
11 itis E virus (HEV) is the causative agent of
hepatitis E,
a major form of viral hepatitis in developi
12 nce entropy and genetic distances during the
hepatitis E acute phase were higher in patients whose in
13 endemic, with frequent seasonal epidemics of
hepatitis E and continuous sporadic cases.
14 yphoid and parathyroid, leishmaniasis, acute
hepatitis E,
and HIV/AIDS), we used natural history mode
15 ra obtained 2 months to 13 years after acute
hepatitis E,
and postinoculation chimpanzee sera), known
16 BcAg]) and the secreted nonparticulate form (
hepatitis e antigen [HBeAg]).
17 esponses are absent in patients with chronic
hepatitis E but become detectable after viral clearance;
18 In total, 2713 acute
hepatitis E cases were diagnosed, of which 1376 were ind
19 How frequently does chronic
hepatitis E develop among human immunodeficiency virus-i
20 In a setting without endemic
hepatitis E disease, there was no evidence that anti-HEV
21 Hepatitis E has a worldwide distribution and causes subs
22 Hepatitis E has been considered to be a travel-associate
23 Autochthonous
hepatitis E has been observed with growing incidence in
24 Sporadic autochthonous cases of
hepatitis E have been reported recently in the United St
25 The dynamics of
hepatitis E have changed recently with an increase in th
26 An increasing incidence of endemic
hepatitis E (
HE) has been reported in developed countrie
27 A case of acute
hepatitis E in a researcher following a scalpel injury w
28 , it can have a role in curbing outbreaks of
hepatitis E in humanitarian crises.
29 py to ribavirin for the treatment of chronic
hepatitis E in immunocompromised patients.
30 To investigate the time trends of
hepatitis E in southeastern Germany, we performed anti-H
31 ly recovered from two patients with clinical
hepatitis E in the United States shared >/=97% amino aci
32 e and liver transplantation in patients with
hepatitis E-
induced acute liver injury and high-grade in
33 ere evaluated for evidence of hepatitis C or
hepatitis E infection and for evidence of severe or prol
34 loping world, viral causes predominate, with
hepatitis E infection recognised as a common cause in ma
35 d treatment, acute liver injury improved and
hepatitis E infection resolved.
36 Increasing evidence indicates that
hepatitis E is a zoonotic disease.
37 We conclude that chronic
hepatitis E is associated with impaired HEV-specific T-c
38 s trapped in Nepal's Kathmandu Valley, where
hepatitis E is hyperendemic, for HEV infection.
39 thermore, a differential diagnosis including
hepatitis E is mandatory in all alloHSCT patients with s
40 is genetically closely related to human HEV,
hepatitis E is now considered a zoonotic disease.
41 HEV is common in the US population, although
hepatitis E is rarely reported.
42 Hepatitis E is recognized as a zoonosis, and swine are k
43 The topic of
hepatitis E is therefore re-emerging and has raised the
44 atitis E virus (HEV), the causative agent of
hepatitis E,
is an important public health concern in ma
45 The disease caused by HEV,
hepatitis E,
is an important public health problem in de
46 dan virus, hantaviruses [Hantaan and Seoul],
hepatitis E,
Marburg, Nipah virus, o'nyong-nyong virus,
47 ion, unrecognized hepatitis D infection, and
hepatitis E may all represent emergent areas of concern.
48 However, in individual cases,
hepatitis E may lead to life-threatening acute liver fai
49 identified in industrialized countries, but
Hepatitis E now is reported increasingly throughout West
50 atitis E virus (HEV), the causative agent of
hepatitis E,
on IFN signaling have not been investigated
51 assembled from blood donors (n = 372), acute
hepatitis E patients (n = 94), five laboratory animals (
52 Hepatitis E represents an alternative diagnosis to some
53 Chronic
hepatitis E should be regarded as another opportunistic
54 Several cases of acute
hepatitis E showed portal and periportal hepatitis, with
55 cute liver injury caused by an autochthonous
hepatitis E that resolved under steroid treatment.
56 A
hepatitis E vaccine could become a powerful new tool in
57 A novel recombinant
hepatitis E vaccine was shown to be safe and effective i
58 Hepatitis E viral (HEV) infection imposes a heavy health
59 Most cases of
hepatitis E viral (HEV) infection in developed countries
60 Acute viral hepatitis resulting due to
hepatitis E viral infection (AVH-E) is often serious in
61 with in vitro transcribed viral genomes, and
hepatitis E virions were released into the culture mediu
62 ted in 75 of 108 (69%) patients, antibody to
hepatitis E virus (anti-HEV) in three patients (3%), and
63 To evaluate antibody to
hepatitis E virus (anti-HEV) seroreactivity, 5000 US blo
64 Baseline prevalence of antibody to
hepatitis E virus (anti-HEV) was 22.5%.
65 mance of existing assays for antibody to the
hepatitis E virus (anti-HEV).
66 haracterized a novel virus, designated avian
hepatitis E virus (avian HEV), from chickens with hepati
67 odies against the emerging zoonotic pathogen
hepatitis E virus (HEV) and enteropathogenic Yersinia sp
68 The thermal stability of virulent
hepatitis E virus (HEV) and hepatitis A virus (HAV) was
69 he host responses to two dissimilar viruses,
hepatitis E virus (HEV) and hepatitis C virus (HCV), wer
70 s have shown a relatively high prevalence of
hepatitis E virus (HEV) antibody.
71 Hepatitis E virus (HEV) can chronically infect immunocom
72 -strands similar to what was observed in the
hepatitis E virus (HEV) capsid structure.
73 Hepatitis E virus (HEV) causes both endemic and epidemic
74 Hepatitis E virus (HEV) causes outbreaks of jaundice ass
75 The RNA genome of the
hepatitis E virus (HEV) contains a hypervariable region
76 ntigen derived from the Meng strain of swine
hepatitis E virus (HEV) differs from that of the Sar-55
77 All patients cleared the
hepatitis E virus (HEV) except for 2 (nonresponders); 1
78 L) structure in the intergenic region of the
hepatitis E virus (HEV) genome in virus replication were
79 Hepatitis E virus (HEV) genotype 3 infections are freque
80 The prevalence of
hepatitis E virus (HEV) genotype 3 infections in the Eng
81 ports of food-borne zoonotic transmission of
hepatitis E virus (HEV) genotype 3, which causes chronic
82 We estimated the global burden of
hepatitis E virus (HEV) genotypes 1 and 2 in 2005.
83 Hepatitis E virus (HEV) has been recognized as a threat
84 Hepatitis E virus (HEV) has emerged as a cause of chroni
85 Hepatitis E virus (HEV) has recently been cloned and seq
86 Moreover, a high prevalence (17%) of
hepatitis E virus (HEV) immunoglobulin G antibodies (ant
87 sceptible humans may serve as a reservoir of
hepatitis E virus (HEV) in areas in which HEV is endemic
88 ce and molecular characterisation studies of
hepatitis E virus (HEV) in England and Wales have been u
89 The recent identification of antibody to
hepatitis E virus (HEV) in pigs, sheep, and cattle and c
90 amination and evaluate the dispersion of the
hepatitis E virus (HEV) in the environment.
91 Hepatitis E virus (HEV) induces acute hepatitis in human
92 Transplant recipients are at risk of
hepatitis E virus (HEV) infection and could be vulnerabl
93 However,
hepatitis E virus (HEV) infection can also be acquired i
94 Hepatitis E virus (HEV) infection causes major epidemics
95 ntiviral immunity and immunopathology during
hepatitis E virus (HEV) infection determines important c
96 Hepatitis E virus (HEV) infection has been proposed as a
97 ical and laboratory features, and outcome of
hepatitis E virus (HEV) infection in children.
98 nd a relatively high seroprevalence (21%) of
hepatitis E virus (HEV) infection in the U.S. general po
99 Acute
hepatitis E virus (HEV) infection is a leading cause of
100 BACKGROUND & AIMS:
Hepatitis E virus (HEV) infection is a major cause of ac
101 Chronic
hepatitis E virus (HEV) infection is a significant clini
102 Hepatitis E virus (HEV) infection is an emerging disease
103 Hepatitis E virus (HEV) infection is increasingly being
104 Hepatitis E virus (HEV) infection is usually self-limite
105 nsitivity to exogenous type I IFN.IMPORTANCE
Hepatitis E virus (HEV) infection typically causes self-
106 protective efficacy of a DNA vaccine against
hepatitis E virus (HEV) infection was tested in cynomolg
107 Prevalence of antibody and risk factors to
hepatitis E virus (HEV) infection were determined in a c
108 There is no established therapy for
hepatitis E virus (HEV) infection.
109 Hepatitis E virus (HEV) infections are a major cause of
110 Antiviral treatment options for chronic
Hepatitis E Virus (HEV) infections are limited and immun
111 Among
hepatitis E virus (HEV) infections diagnosed in 2011 by
112 lid-organ-transplant recipients with chronic
hepatitis E virus (HEV) infections were given ribavirin
113 There is little knowledge about how
hepatitis E virus (HEV) inhibits induction of host IFNs,
114 Hepatitis E virus (HEV) is a causative agent of acute he
115 Hepatitis E virus (HEV) is a human pathogen that causes
116 Hepatitis E virus (HEV) is a major cause of acute viral
117 The ORF3 protein of
hepatitis E virus (HEV) is a multifunctional protein imp
118 Hepatitis E virus (HEV) is a new causative agent of chro
119 Hepatitis E virus (HEV) is a single-strand positive-sens
120 Hepatitis E virus (HEV) is an emerging virus causing epi
121 Hepatitis E virus (HEV) is an important but extremely un
122 Hepatitis E virus (HEV) is an important but extremely un
123 Hepatitis E virus (HEV) is an important cause of enteric
124 Hepatitis E virus (HEV) is an important human pathogen,
125 Hepatitis E virus (HEV) is an important human pathogen.
126 Hepatitis E virus (HEV) is an important public health co
127 Hepatitis E virus (HEV) is an unclassified virus with a
128 Hepatitis E virus (HEV) is believed to be transmitted by
129 Exposure to
hepatitis E virus (HEV) is common in the United States,
130 Hepatitis E virus (HEV) is considered a zoonotic infecti
131 Hepatitis E virus (HEV) is endemic in many developing an
132 Hepatitis E virus (HEV) is increasingly acknowledged as
133 ferent hosts in genotypes 3 and 4.IMPORTANCE
Hepatitis E virus (HEV) is increasingly recognized as a
134 Hepatitis E virus (HEV) is prevalent and causes disease
135 Although
hepatitis E virus (HEV) is regarded as a self-limiting i
136 Hepatitis E virus (HEV) is the causative agent of hepati
137 Hepatitis E virus (HEV) is the leading cause of enterica
138 Hepatitis E virus (HEV) is the major cause of entericall
139 Hepatitis E virus (HEV) is the most common cause of acut
140 Hepatitis E virus (HEV) is the most common cause of acut
141 The RNA virus,
hepatitis E virus (HEV) is the most or second-most impor
142 Hepatitis E virus (HEV) is yearly responsible for approx
143 To determine the initiation strategy of the
hepatitis E virus (HEV) open reading frame 3 (ORF3), we
144 The
hepatitis E virus (HEV) polyproline region (PPR) is an i
145 As a positive-strand RNA virus,
hepatitis E virus (HEV) produces an intermediate negativ
146 The antigenic composition of the
hepatitis E virus (HEV) protein encoded by open reading
147 Hepatitis E virus (HEV) recently has been shown to be an
148 Hepatitis E virus (HEV) replication is not well understo
149 The mechanism of
hepatitis E virus (HEV) replication remains largely unkn
150 The
hepatitis E virus (HEV) RNA concentrations were determin
151 Hepatitis E virus (HEV) RNA replication occurred in seve
152 Hepatitis E virus (HEV) seroprevalences of 0.3%-53% were
153 Here, we report that the macro domain from
hepatitis E virus (HEV) serves as an ADP-ribose-protein
154 The
hepatitis E virus (HEV) sheds into feces as nonenveloped
155 The classification of
hepatitis E virus (HEV) variants is currently in transit
156 with HUE (58.3%) and the pooled library, and
hepatitis E virus (HEV) was detected in 2 individuals wi
157 nst the ORF2 protein of the SAR-55 strain of
hepatitis E virus (HEV) were isolated by phage display f
158 Avian
hepatitis E virus (HEV), a novel virus identified from c
159 Hepatitis E virus (HEV), a single-stranded positive-sens
160 Hepatitis E virus (HEV), a small, non-enveloped RNA viru
161 ut how broadly enzootic its causative agent,
hepatitis E virus (HEV), is remains controversial.
162 Hepatitis E virus (HEV), rotavirus (RV), and astrovirus
163 The effects of
hepatitis E virus (HEV), the causative agent of hepatiti
164 Hepatitis E virus (HEV), the causative agent of hepatiti
165 s a striking resemblance to the structure of
hepatitis E virus (HEV)-like particles, as previously pr
166 Prior to the recent discovery of the swine
hepatitis E virus (swine HEV) in pigs from the midwester
167 Swine
hepatitis E virus (swine HEV), the first animal strain o
168 A novel virus, designated swine
hepatitis E virus (swine HEV), was identified in pigs.
169 gical and molecular techniques (detection of
hepatitis E virus [HEV] RNA from stool and serum samples
170 ectious cDNA clone of a genotype 3 strain of
hepatitis E virus adapted to growth in HepG2/C3A human h
171 elm mottle virus, in animal viruses like the
hepatitis E virus and the caprine encephalitis virus, an
172 If the occurrence of
hepatitis E virus antibody (anti-HEV) in regions where t
173 Based on a
hepatitis E virus capsid model, we performed homology mo
174 a-barrel structure that is also found in the
hepatitis E virus capsid protrusions, suggesting a close
175 owever, recent work on hepatitis A virus and
hepatitis E virus challenges this long-held tenet.
176 , the ICTV approved a proposal to remove the
hepatitis E virus from the Caliciviridae into an "unassi
177 Hepatitis E virus genotype 1 strain Sar55 replicated in
178 that sofosbuvir inhibits the replication of
hepatitis E virus genotype 3 both in subgenomic replicon
179 Infection with
hepatitis E virus genotype 3 may result in chronic hepat
180 Hepatitis E virus has been reported to result in chronic
181 Hepatitis E virus IgM and IgG reactivity was determined.
182 Hepatitis E virus IgM and IgG reactivity.
183 The seroprevalence of antibody to
hepatitis E virus in this population was 13.6%; to Barto
184 ral blood and liver tissue revealed an acute
hepatitis E virus infection (genotype 3).
185 Hepatitis E virus infection causes an acute hepatitis wi
186 Ribavirin is efficient at treating chronic
hepatitis E virus infection in solid-organ transplant pa
187 ts with a solid-organ transplant and chronic
hepatitis E virus infection were given ribavirin for 3 m
188 Chronic
hepatitis E virus infection with rapid progression to ci
189 Hepatitis E virus is a nonenveloped RNA virus.
190 Hepatitis E virus recombinant genomes transcribed in vit
191 Hepatitis E virus replicons containing the neomycin resi
192 Hepatitis E virus RNA levels also remained detectable in
193 ul new tool in the prevention and control of
hepatitis E virus transmission and disease.
194 ly efficiently transfected and infected with
hepatitis E virus was identified.
195 An infectious cDNA clone of
hepatitis E virus was mutated in order to prevent synthe
196 related to the P1 domain in calicivirus and
hepatitis E virus, suggesting a possible evolutionary re
197 In the case of
hepatitis E virus, the adjacent viral helicase domain dr
198 Hepatitis E Virus-like particles self-assemble in to non
199 We also recruited non-
hepatitis E virus-related pregnant (P), ALF-NE (n = 5) a
200 ulation: human T-cell leukemia virus type 1;
hepatitis E virus; bocavirus; KI and WU polyomaviruses;
201 itis-B virus (HBV), hepatitis-C virus (HCV),
hepatitis-E virus (HEV), dengue virus (DENV), and West N
202 en-free pigs were inoculated with one of two
hepatitis E viruses (HEV) (one recovered from a pig and
203 Genotype 1
hepatitis E viruses (HEVs) are restricted to primate hos
204 ast decade, an increasing frequency of acute
hepatitis E was noted in Germany and other European coun
205 Until recently,
hepatitis E was rarely identified in industrialized coun
206 ients with anti-HEV IgM indicated that acute
hepatitis E was the most likely diagnosis for 7 and migh
207 On 11 December 2013, 3 clustered cases of
hepatitis E were reported on a French coastal island.
208 erived food products to post-transplantation
hepatitis E,
which, if detected at early stages, can be
209 ples collected from 15 patients with chronic
hepatitis E who were recipients of solid-organ transplan